Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of amino acid metabolism (HP:0004337)help
Parent Node:
expand
Abnormal circulating aspartate family amino acid concentration (HP:0010899)help
..Starting node
..expand
Abnormal circulating lysine concentration (HP:0010908)help
Term ID: 10908
Name: Abnormal circulating lysine concentration
Synonym: Abnormality of lysine metabolism
Definition: Any deviation from the normal concentration of lysine in the blood circulation.
Comments:
Reference: HP:0010908
Genes and Diseases:
 
       Child Nodes:
........expandHyperlysinemia (HP:0002161) help
........expandHyperlysinuria (HP:0003297) help

 Sister Nodes: 
..expandAbnormal circulating methionine concentration (HP:0010901) help
..expandAbnormal circulating threonine concentration (HP:0010900) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010908HP:0010908Abnormal circulating lysine concentration0AASS CL E G H1015717366ORPHA:2203Hyperlysinemia15
HP:0010908HP:0010908Abnormal circulating lysine concentration0AASS CL E G H1015717366OMIM:238700Hyperlysinemia, type I15
HP:0010908HP:0010908Abnormal circulating lysine concentration0AASS CL E G H1015717366ORPHA:3124Saccharopinuria15
HP:0010908HP:0010908Abnormal circulating lysine concentration0MICU1 CL E G H103671530OMIM:615673Myopathy with extrapyramidal signs14
HP:0010908HP:0010908Abnormal circulating lysine concentration0NADK2 CL E G H13368626404OMIM:6160342,4-Dienoyl-Coa reductase deficiency14
HP:0010908HP:0010908Abnormal circulating lysine concentration0NADK2 CL E G H13368626404ORPHA:431361Progressive encephalopathy with leukodystrophy due to DECR deficiency14
HP:0010908HP:0010908Abnormal circulating lysine concentration0SLC25A13 CL E G H1016510983ORPHA:247598Neonatal intrahepatic cholestasis due to citrin deficiency82
HP:0010908HP:0034463Hydroxylysinemia1 CL E G H
HP:0010908HP:0500142Hypolysinemia1 CL E G H
HP:0010908HP:0002161Hyperlysinemia1AASS CL E G H1015717366ORPHA:2203HyperlysinemiaHP:0040282 - Frequent15
HP:0010908HP:0002161Hyperlysinemia1AASS CL E G H1015717366OMIM:238700Hyperlysinemia, type I.15
HP:0010908HP:0002161Hyperlysinemia1AASS CL E G H1015717366ORPHA:3124SaccharopinuriaHP:0040281 - Very frequent15
HP:0010908HP:0002161Hyperlysinemia1MICU1 CL E G H103671530OMIM:615673Myopathy with extrapyramidal signs14
HP:0010908HP:0002161Hyperlysinemia1NADK2 CL E G H13368626404OMIM:6160342,4-Dienoyl-Coa reductase deficiency.14
HP:0010908HP:0002161Hyperlysinemia1NADK2 CL E G H13368626404ORPHA:431361Progressive encephalopathy with leukodystrophy due to DECR deficiencyHP:0040282 - Frequent14
HP:0010908HP:0002161Hyperlysinemia1SLC25A13 CL E G H1016510983ORPHA:247598Neonatal intrahepatic cholestasis due to citrin deficiencyHP:0040282 - Frequent82


Genes (4) :AASS MICU1 NADK2 SLC25A13

Diseases (7) :ORPHA:2203 OMIM:238700 ORPHA:3124 OMIM:615673 OMIM:616034 ORPHA:431361 ORPHA:247598
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.